Browsing by Contributors Pathan, AA

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 7 of 7
PreviewIssue DateTitleContributor(s)
2012A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicityRowland, R; Brittain, N; Poulton, ID; Minassian, AM; Sander, C; Porter, DW; Satti, I; Pathan, AA; Lawrie, AM; McShane, H; Williams, N
2007Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: Different boosting intervals and implications for efficacy trialsPathan, AA; Sander, CR; Fletcher, HA; Poulton, I; Alder, NC; Beveridge, NER; Whelan, KT; Hill, AVS; McShane, H
2010Expansion of anti-AFP Th1 and Tc1 responses in hepatocellular carcinoma occur in different stages of diseaseAlisa, A; Boswell, S; Anastassiou, J; Pathan, AA; Williams, R
2009Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from mycobacterium tuberculosisSmith, SG; Joosten, SA; Verscheure, V; Pathan, AA; McShane, H; Ottenhoff, THM; Dockrell, HM; Mascart, F
2013Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85AMatsumiya, M; Stylianou, E; Griffiths, K; Lang, Z; Meyer, J; Harris, SA; Rowland, R; Minassian, AM; Pathan, AA; Fletcher, H; McShane, H
2009Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in mycobacterium tuberculosis–infected individualsSander, CR; Pathan, AA; Beveridge, NER; Poulton, I; Minassian, A; Alder, N; Van Wijgerden, J; Hill, AVS; Gleeson, FV; Davies, RJO; Pasvol, G; McShane, H
2009Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: Comparison with boosting with a new TB vaccine, MVA85AWhelan, KT; Pathan, AA; Sander, CR; Fletcher, HA; Poulton, I; Alder, NC; Hill, AVS; McShane, H